InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: DCornerStone post# 54693

Tuesday, 04/20/2021 9:28:16 PM

Tuesday, April 20, 2021 9:28:16 PM

Post# of 118379
Thanks!

I'm Long on this Play! Just opened a position recently and glad I did at the current ridiculously low PPS! Talk about a major gift! If this company was on NASDAQ trading at $5 it would be getting snapped up by millions of shares daily sending its pps into the $10-$15 range AND it would still be getting snapped by millions of shares daily in that range as well!

WHY?? Their extensive portfolio of Patents they have that are destine to transition into their extensive "Clinical Trials Pipeline" AND ALSO what they have center stage with their new class of Cancer Immunotherapy based on mRNA modulation that's a promising treatment for Pancreatic Cancer which is presently the 3rd leading cause of deaths by cancers. By 2030, it's expected to move UP to the 2nd leading cause of all cancer related deaths. Presently there are no cures for pancreatic cancer and chemotherepy is an extremely poor treatment prospect with little or no effect.

Essentially their mRNA new drug class qualifies as "disruptive biotechnology" which is the very reason BigPharmas are interested in partnering with them via licensing and/or buy out, which IMO is bound to happen sooner or later.

Great entry point at current pps! Nearly the same as E*NZC about this time last year. Great time to load massively. I already have with a few Mil Shares, and will average down on any and all dips or artificial drops in the PPS due to MM-Hedge manipulation. They can't do that forever, as it's contrary to "making a market", and soon trading comes to a near stand still or ultra low trading volume like it did last week or the week before.

I'm not going to focus on that however for reason it's a distraction relative to the intrinsic value of RGBP with its multiple Patents, recent licensing to Oncology Pharma that's currently trading at $35/Share, then there's royalities from that partnership that will soon begin falling to RGBP's bottom line, and in addition to that they will receive a percentage of all sub-licensing deals by Oncology Pharma to other Big Pharmas.

Can't miss with this one unlike any I've seen before with the exception of E*NZC although they are at least 6 months to 1 year behind RBGP in their progress.

Pushing forward to build a block of several more Million Shares and now's the time to do that!

The ultimate situation that may come out of this is their current BigPharma partner MIGHT decide to buy them out altogether which IF that happens, it would most likely be going into Phase III Clinical Trials that's for evaluating the clinical efficacy of their drug compared to similar pharmaceuticals on the market although there are NONE in the same class! Phase IV is just a formality that takes place after the drug has already been given a name and is being marketed globally, and primarily is for evaluation of long term performance including risks & benefits. By Phase IV the drug has already been bought out by a BigPharma along the way IF the Patent wasn't with a BigPharma from the Get Go!

This is very likely what's going to happen and I would give that about a near 100% chance for reason they're going to need a BigPharma partner who's cash heavy to underwrite the expense of Clinical Trials as well as the marketing and advertisement which cost Millions by itself.

Cytodyn followed this exact same path when they were on the OTC trading at 0.26 and suddenly shot up to $10 not long after they announced a BigPharma partner to do the very things I mentioned here.

It's very clear & obvious to me that RGBP is going to follow this same path. They need BIG BUCKS with a BigPharma who has the infrastructure and expertise to do all these things and a lot more.

Cytodyne's BigPharma partner performed all the required clinical trials and marketing, which they could of never done on their own, way too expensive and enormous man power requirement on many levels of expertise, including regulatory connections to push things through.

Hope this info helps shed light for everyone here on this Rising Star!

My advice to all is to ignore the naked short selling of the Hedges-MMs behind the scene and take full advantage of what they're doing by building a large position while you can at the current major discount level for reason it's NOT going to last forever. I sense they are beginning to back off about now anyway due to many factors in play coming at them.

Be well and prosper...